168 related articles for article (PubMed ID: 8130209)
21. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
[TBL] [Abstract][Full Text] [Related]
22. Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.
Corti A; Sarubbi E; Soffientini A; Nolli ML; Zanni A; Galimberti M; Parenti F; Cassani G
Thromb Haemost; 1989 Nov; 62(3):934-9. PubMed ID: 2480654
[TBL] [Abstract][Full Text] [Related]
23. Domain structure, stability and domain-domain interactions in recombinant factor XIII.
Kurochkin IV; Procyk R; Bishop PD; Yee VC; Teller DC; Ingham KC; Medved LV
J Mol Biol; 1995 Apr; 248(2):414-30. PubMed ID: 7739050
[TBL] [Abstract][Full Text] [Related]
24. 1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.
Byeon IJ; Kelley RF; Llinás M
Biochemistry; 1989 Nov; 28(24):9350-60. PubMed ID: 2558718
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of the kringle domain from urokinase-type plasminogen activator.
Li X; Bokman AM; Llinás M; Smith RA; Dobson CM
J Mol Biol; 1994 Feb; 235(5):1548-59. PubMed ID: 8107091
[TBL] [Abstract][Full Text] [Related]
26. Heparin binding to the urokinase kringle domain.
Stephens RW; Bokman AM; Myöhänen HT; Reisberg T; Tapiovaara H; Pedersen N; Grøndahl-Hansen J; Llinás M; Vaheri A
Biochemistry; 1992 Aug; 31(33):7572-9. PubMed ID: 1510944
[TBL] [Abstract][Full Text] [Related]
27. Binding of nonphysiological protein and peptide substrates to proteases: differences between urokinase-type plasminogen activator and trypsin and contributions to the evolution of regulated proteolysis.
Bergstrom RC; Coombs GS; Ye S; Madison EL; Goldsmith EJ; Corey DR
Biochemistry; 2003 May; 42(18):5395-402. PubMed ID: 12731881
[TBL] [Abstract][Full Text] [Related]
28. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Biochemistry; 1993 May; 32(18):4727-37. PubMed ID: 8387813
[TBL] [Abstract][Full Text] [Related]
29. Selective Stabilization and Destabilization of Protein Domains in Tissue-Type Plasminogen Activator Using Formulation Excipients.
Robinson MJ; Matejtschuk P; Longstaff C; Dalby PA
Mol Pharm; 2019 Feb; 16(2):744-755. PubMed ID: 30565948
[TBL] [Abstract][Full Text] [Related]
30. Relationship between equilibrium amide proton exchange behavior and the folding pathway of barnase.
Perrett S; Clarke J; Hounslow AM; Fersht AR
Biochemistry; 1995 Jul; 34(29):9288-98. PubMed ID: 7626599
[TBL] [Abstract][Full Text] [Related]
31. Conformations and stabilities of human Glu1- and Lys78-plasminogen and of the fragments mini- and microplasminogen, analysed by circular dichroism and differential scanning calorimetry.
Misselwitz R; Welfle K; Welfle H
Int J Biol Macromol; 1994 Aug; 16(4):187-94. PubMed ID: 7848966
[TBL] [Abstract][Full Text] [Related]
32. Structure of human urokinase plasminogen activator in complex with its receptor.
Huai Q; Mazar AP; Kuo A; Parry GC; Shaw DE; Callahan J; Li Y; Yuan C; Bian C; Chen L; Furie B; Furie BC; Cines DB; Huang M
Science; 2006 Feb; 311(5761):656-9. PubMed ID: 16456079
[TBL] [Abstract][Full Text] [Related]
33. Structure and function of the epidermal growth factor domain of P-selectin.
Freedman SJ; Sanford DG; Bachovchin WW; Furie BC; Baleja JD; Furie B
Biochemistry; 1996 Oct; 35(43):13733-44. PubMed ID: 8901515
[TBL] [Abstract][Full Text] [Related]
34. Folding of subtilisin BPN': role of the pro-sequence.
Eder J; Rheinnecker M; Fersht AR
J Mol Biol; 1993 Sep; 233(2):293-304. PubMed ID: 8377204
[TBL] [Abstract][Full Text] [Related]
35. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
[TBL] [Abstract][Full Text] [Related]
36. Prediction and analysis of structure, stability and unfolding of thermolysin-like proteases.
Vriend G; Eijsink V
J Comput Aided Mol Des; 1993 Aug; 7(4):367-96. PubMed ID: 8229092
[TBL] [Abstract][Full Text] [Related]
37. The solution structure and backbone dynamics of the fibronectin type I and epidermal growth factor-like pair of modules of tissue-type plasminogen activator.
Smith BO; Downing AK; Driscoll PC; Dudgeon TJ; Campbell ID
Structure; 1995 Aug; 3(8):823-33. PubMed ID: 7582899
[TBL] [Abstract][Full Text] [Related]
38. Fragment reconstitution of a small protein: folding energetics of the reconstituted immunoglobulin binding domain B1 of streptococcal protein G.
Honda S; Kobayashi N; Munekata E; Uedaira H
Biochemistry; 1999 Jan; 38(4):1203-13. PubMed ID: 9930980
[TBL] [Abstract][Full Text] [Related]
39. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
[TBL] [Abstract][Full Text] [Related]
40. Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3.
Bang P; Fielder PJ
Endocrinology; 1997 Sep; 138(9):3912-7. PubMed ID: 9275081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
